Search
Close
Search
Advanced Search
Search Menu

Abstract

Aims Surgical myectomy has been successfully used to treat patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). More recently, alcohol septal ablation has been advocated as a less invasive, but equally effective alternative therapy. The aim of this non-randomized cohort study was to compare subjective and objective outcomes in patients undergoing these therapies.

Methods Forty-four patients (25 male; age 41±15 years) with symptomatic drug-refractory obstructive HCM were studied. Twenty-four patients underwent surgical myectomy and 20 alcohol septal ablation. All patients underwent clinical evaluation, echocardiography and upright maximal cardiopulmonary exercise testing using a cycle ergometer before and following their intervention.

Results Peak gradient was reduced to a similar extent by both modalities (myectomy: 83±23 to 15±10mmHg (P<0·000001); ablation: 91±18 to 22±14mmHg (P<0·000002);P =0·48 for myectomy vs ablation) and led to similar improvements in NYHA class (myectomy: 2·4±0·6 to 1·5±0·7 (P<0·00001); ablation: 2·3±0·5 to 1·7±0·8 (P<0·0001);P=0·3 for myectomy vs ablation). Myectomy resulted in a greater improvement in peak oxygen consumption (myectomy: 16·4±5·8 to 23·1±7·1ml.kg−1 min−1 (P<0·00002); ablation: 16·2±5·2 to 19·3±6·1ml.kg−1 min−1 (P<0·05);P <0·05 for myectomy vs ablation) and work rate achieved (myectomy: 130±57 to 161±60 watts (P<0·04); ablation: 121±53 to 137±51 watts (P=0·11);P <0·05 for myectomy vs ablation).

Conclusion Surgical myectomy and alcohol septal ablation are equally effective at reducing obstruction and subjective exercise limitation in appropriately selected patients. However, the superior effect of surgical myectomy on exercise test parameters suggests that surgery remains the gold standard against which new treatment modalities should be compared. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.

Hypertrophic cardiomyopathy, obstruction, myectomy, alcohol septal ablation, peak oxygen consumption
f1

Correspondence: Dr P. M. Elliott, Department of Cardiological Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, U.K.

References

1

Henry
WL
, Clark CE, Griffith JM, Epstein SE. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis).
Am J Cardiol
.
1975
;
35
:
337
–345

2

Ciro
E
, Nichols PF III, Maron BJ. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis.
Circulation
.
1983
;
67
:
1227
–1233

3

Maron
BJ
, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).
N Engl J Med
.
1987
;
316
:
780
–789

4

McCully
RB
, Nishimura RA, Tajik AJ, Schaff V, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy.
Circulation
.
1996
;
94
:
467
–471

5

Maron
BJ
, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.
Circulation
.
1978
;
57
:
1205
–1213

6

Koch
JP
, Maron BJ, Epstein SE, Morrow AG. Results of operation for obstructive hypertrophic cardiomyopathy in the elderly. Septal myotomy and myectomy in 20 patients 65 years of age or older.
Am J Cardiol
.
1980
;
46
:
963
–966

7

Schulte
HD
, Borisov K, Gams E, Gramsch-Zabel H, Losse B, Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy—2long-term results after surgical therapy.
Thorac Cardiovasc Surg
.
1999
;
47
:
213
–218

8

Williams
WG
, Wigle ED, Rakowski H, Smallhorn J, LeBlanc J, Trusler GA. Results of surgery for hypertrophic obstructive cardiomyopathy.
Circulation
.
1987
;
76
:
V104
–108

9

Schoendube
FA
, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus.
Circulation
.
1995
;
92
:
II122
–7

10

Morrow
AG
, Reitz BA, Epstein SE. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients.
Circulation
.
1975
;
52
:
88
–102

11

Sigwart
U
. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.
Lancet
.
1995
;
346
:
211
–214

12

Nagueh
SF
, Ommen SR, Lakkis NM. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
J Am Coll Cardiol
.
2001
;
38
:
1701
–1706

13

Qin
JX
, Shiota T, Lever HM. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
J Am Coll Cardiol
.
2001
;
38
:
1994
–2000

14

Fananapazir
L
, McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.
J Am Coll Cardiol
.
1998
;
31
:
259
–264

15

Nishimura
RA
, Trusty JM, Hayes DL. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
J Am Coll Cardiol
.
1997
;
29
:
435
–441

16

Sharma
S
, Elliott P, Whyte G. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy.
Am J Cardiol
.
2000
;
86
:
162
–168

17

Knight
C
, Kurbaan AS, Seggewiss H. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.
Circulation
.
1997
;
95
:
2075
–2081

18

Kappenberger
L
, Linde C, Daubert C. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group.
Eur Heart J
.
1997
;
18
:
1249
–1256

19

Maron
BJ
, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
Circulation
.
1999
;
99
:
2927
–2933

20

Borer
JS
, Bacharach SL, Green MV. Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS.
Circulation
.
1979
;
60
:
82
–87

21

Mazur
W
, Nagueh SF, Lakkis NM. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Circulation
.
2001
;
20;103
:
1492
–1496

PDF
This content is only available as a PDF.
The European Society of Cardiology
Download all slides